col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


73 Ergebisse       Seite 1

 [1] 
Silicea - Poligraf, LLC: CARDIOVASCULAR THERAPY AND PREVENTION
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Mai―17 Conventional (D-dimer) and potential (pentraxin 3 and sST2) biomarkers in long-term prognosis of adverse cardiovascular events in COVID-19 survivors without significant cardiovascular diseases T. V. Kanaeva, N. A. Karoli
2 [GO] 2025―Mrz―09 COVID-19 and smoking in Russia: how are hospitalizations, course, and outcomes of coronavirus infection related to tobacco use? M. G. Gambaryan, M. G. Chashchin, A. V. Kontsevaya, A. Yu. Gorshkov, O. M. Drapkina
3 [GO] 2025―Feb―17 Vaccination against the SARS-CoV-2 in individuals with comorbidities S A Berns, M G Chashсhin, A Yu Gorshkov, O V Zhdanova, L N Ryzhakova, O A Litinskaya, O M Drapkina
4 [GO] 2025―Feb―17 COVID-19 incidence after vaccination with different types of vaccines against SARS-CoV-2 O. M. Drapkina, S. A. Berns, M. G. Chashсhin, A. Yu. Gorshkov, O. V. Zhdanova, L. N. Ryzhakova, et al. (+2)
5 [GO] 2024―Nov―26 Associations of levels of biochemical markers of chronic and acute inflammation, abdominal obesity and post-COVID syndrome in COVID-19 convalescents A. A. Karaseva, A. D. Afanaseva, E. V. Garbuzova, E. V. Kashtanova, Ya. V. Polonskaya, V. S. Shramko, et al. (+2)
6 [GO] 2024―Feb―26 Has COVID-19 affected regional mortality from acute coronary artery disease? (comparison of two periods of 2017-2019 and 2020-2022) I. V. Samorodskaya, M. G. Bubnova, O. A. Akulova
7 [GO] 2024―Feb―09 Severity and duration of immune response in people of different age categories after SARS-CoV-2 revaccination O. M. Drapkina, S. A. Berns, M. G. Chashchin, A. Yu. Gorshkov, O. V. Zhdanova, L. N. Ryzhakova
8 [GO] 2024―Feb―09 Booster vaccination against the SARS-CoV-2: mechanisms and efficiency S. A. Berns, A. V. Veremeyev, A. A. Savicheva, A. Yu. Gorshkov, O. M. Drapkina
9 [GO] 2024―Feb―02 Obesity in the Russian population during the COVID-19 pandemic and associated factors. Data from the ESSE-RF3 study Yu. A. Balanova, O. M. Drapkina, V. A. Kutsenko, A. E. Imaeva, A. V. Kontsevaya, S. A. Maksimov, et al. (+61)
10 [GO] 2024―Feb―02 Hypertension in the Russian population during the COVID-19 pandemic: sex differences in prevalence, treatment and its effectiveness. Data from the ESSE-RF3 study Yu. A. Balanova, O. M. Drapkina, V. A. Kutsenko, A. E. Imaeva, A. V. Kontsevaya, S. A. Maksimov, et al. (+61)
11 [GO] 2024―Feb―02 Levels and types of physical activity in Russia according to the ESSE-RF study: is there a trace of the COVID-19 pandemic? M. B. Kotova, S. A. Maksimov, S. A. Shalnova, A. V. Kontsevaya, Yu. A. Balanova, A. E. Imaeva, et al. (+53)
12 [GO] 2024―Feb―02 Proportion of COVID-19 survivors in 2020-2022 in the Russian population (according to the ESSE-RF3 study) G. A. Muromtseva, S. A. Shalnova, V. A. Kutsenko, E. M. Filichkina, Yu. A. Balanova, S. E. Evstifeeva, et al. (+58)
13 [GO] 2024―Feb―02 Adherence to a healthy lifestyle in Russia according to the ESSE-RF study: is there a COVID-19 trace? О. M. Drapkina, M. B. Kotova, S. A. Maksimov, S. A. Shalnova, Yu. A. Balanova, A. E. Imaeva, et al. (+55)
14 [GO] 2024―Feb―02 Alcohol consumption patterns in Russia according to the ESSE-RF study: is there a COVID-19 trace? S. A. Maksimov, S. A. Shalnova, Yu. A. Balanova, A. V. Kontsevaya, A. E. Imaeva, V. A. Kutsenko, et al. (+53)
15 [GO] 2023―Dez―11 Study of the metabolome features of patients with COVID-19 Y. V. Russkikh, N. N. Sushentseva, O. S. Popov, S. V. Apalko, A. Yu. Anisenkova, S. V. Mosenko, et al. (+2)
16 [GO] 2023―Nov―30 Two-year outcomes in patients after hospitalization for COVID-19: data from the TARGET-VIP registry M. M. Lukyanov, E. Yu. Andreenko, S. Yu. Martsevich, N. P. Kutishenko, V. P. Voronina, V. A. Dindikova, et al. (+10)
17 [GO] 2023―Nov―30 Analysis of the humoral and cell-mediated immune response in heterologous and homologous SARS-CoV-2 revaccination O. M. Drapkina, M. G. Chashchin, S. A. Berns, A. Yu. Gorshkov, O. V. Zhdanova, L. N. Ryzhakova, O. A. Litinskaya
18 [GO] 2023―Nov―01 Heart rate variability in patients with acute ST-segment elevation myocardial infarction after COVID-19 V. P. Mikhin, O. A. Osipova, A. I. Gindler, A. S. Brizhaneva, N. V. Zaikina, M. P. Zaikina, et al. (+3)
19 [GO] 2023―Nov―01 Changes of clinical and echocardiographic parameters within a year after COVID-19 pneumonia in patients without cardiovascular diseases, depending on the obesity presence E. I. Yaroslavskaya, N. E. Shirokov, D. V. Krinochkin, V. D. Garanina, I. O. Korovina, N. A. Osokina, et al. (+3)
20 [GO] 2023―Jul―21 Short- and long-term outcomes of patients with COVID-19 and acute kidney injury Yu. V. Khruleva, M. A. Efremovtseva, Yu. A. Timofeeva, M. V. Vatsik-Gorodetskaya, Zh. D. Kobalava
21 [GO] 2023―Jun―22 Structural and functional properties of arteries in COVID-19 survivors V. E. Oleinikov, I. V. Avdeeva, K. N. Polezhaeva, K. I. Pavlenko, N. A. Borisova, A. A. Khromova, A. V. Kulyutsin
22 [GO] 2023―Apr―11 Relationship between latent left ventricular contractile dysfunction and signs of immune inflammation in patients with COVID-19 pneumonia N. E. Shirokov, E. I. Yaroslavskaya, D. V. Krinochkin, N. A. Musikhina, T. I. Petelina, N. A. Osokina
23 [GO] 2023―Mrz―11 Telemedicine technologies in improving the effectiveness of follow-up monitoring of patients with lower extremity peripheral artery disease during the COVID-19 pandemic S. A. Makarov, K. V. Smirnov, Ya. V. Danilchenko
24 [GO] 2023―Mrz―11 Mitral valve chordal rupture against the background of cardiac SARS-CoV-2 infection. Cases series Z. N. Sukmarova, L. A. Matskevich, Yu. V. Ovchinnikov, O. I. Goloshchapov, A. M. Lila
25 [GO] 2023―Jan―19 Changes in NT-proBNP levels in patients with sinus tachycardia after COVID-19 V. I. Podzolkov, A. E. Bragina, A. I. Tarzimanova, T. S. Vargina, E. S. Ogibenina, I. I. Shvedov, et al. (+2)
26 [GO] 2023―Jan―19 Medical treatment of patients with cardiovascular diseases during the first year after hospitalization for COVID-19 N. P. Kutishenko, M. M. Lukyanov, S. Yu. Martsevich, A. A. Pulin, E. Yu. Andreenko, V. P. Voronina, et al. (+12)
27 [GO] 2023―Jan―19 Detection rate and characteristics of heart failure, depending on the diagnostic criteria in COVID-19 survivors one year after hospitalization Yu. V. Mareev, M. M. Lukyanov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, et al. (+13)
28 [GO] 2023―Jan―19 Reactogenicity of various COVID-19 vaccination regimens O. M. Drapkina, S. A. Berns, A. Yu. Gorshkov, L. N. Ryzhakova, O. V. Zhdanova, M. G. Chaschin, O. A. Litinskaya
29 [GO] 2023―Jan―19 Comparative assessment of the immunogenicity of various revaccination regimens against the SARS-CoV-2 O. M. Drapkina, S. A. Berns, A. Yu. Gorshkov, L. N. Ryzhakova, O. V. Zhdanova, M. G. Chaschin, et al. (+3)
30 [GO] 2022―Nov―05 Effect of spironolactone therapy on the activity of the matrix metalloproteinase system in patients with heart failure after COVID-19 V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, I. I. Shvedov, E. E. Bykova, А. A. Ivannikov, et al. (+2)
31 [GO] 2022―Sep―08 Comparison of inhospital outcomes after open thrombectomy versus conservative therapy in patients with acute lower limb artery thrombosis and COVID-19 I. A. Abdullaev, S. V. Abasova, L. B. Danilchuk, V. A. Shramko, E. V. Sokolova, A. V. Korotkikh, et al. (+3)
32 [GO] 2022―Aug―11 Comparative efficacy of ivabradine and beta-blockers in the treatment of tachycardia in patients after COVID-19 V. I. Podzolkov, A. E. Bragina, A. I. Tarzimanova, E. S. Ogibenina, I. I. Shvedov, E. E. Bykova, A. A. Ivannikov
33 [GO] 2022―Aug―11 Features of the pathogenesis and course of myocardial infarction in COVID-19 patients: a descriptive review M. G. Chashchin, A. Yu. Gorshkov, A. V. Strelkova, O. M. Drapkina
34 [GO] 2022―Jul―24 Assessment of the quality of research and practice events using telemedicine technologies at the National Medical Research Center for Therapy and Preventive Medicine during the COVID-19 pandemic O. M. Drapkina, R. N. Shepel, S. Yu. Astanina, T. V. Vakhovskaya, T. V. Sapronova, T. V. Samoilov
35 [GO] 2022―Jul―09 Russian-language publication activity of medical researchers in during the COVID-19 pandemic: “post-COVID-19 syndrome” O. T. Kim, O. M. Drapkina, Yu. V. Rodionova
36 [GO] 2022―Jul―09 New SARS-CoV-2 Omicron variant - clinical picture, treatment, prevention (literature review) V. I. Vechorko, O. V. Averkov, A. A. Zimin
37 [GO] 2022―Apr―07 Additional evidence against widespread use of inpatient antiplatelet therapy in coronavirus infection: data from a randomized controlled trial I. S. Yavelov
38 [GO] 2022―Mrz―28 Place of renin-angiotensin-aldosterone system inhibitors and statins in the treatment of cardiovascular patients in the context of COVID-19 pandemic E. V. Sayutina, L. I. Butorova, E. M. Tuaeva, M. A. Osadchuk, M. M. Shamuilova
39 [GO] 2022―Mrz―28 NEWS2, 4C Mortality Score, COVID-GRAM, Sequential Organ Failure Assessment Quick scales as outcomes assessment tools for severe COVID-19 (pilot retrospective cohort study) V. I. Vechorko, O. V. Averkov, D. V. Grishin, A. A. Zimin
40 [GO] 2022―Feb―28 Health care quality and changes in the clinical characteristics of patients with non-ST elevation acute coronary syndrome in a regional vascular center during the COVID-19 pandemic S. V. Dil, S. V. Demyanov, V. V. Ryabov, S. V. Popov
41 [GO] 2022―Feb―28 Use of non-steroidal anti-inflammatory drugs during the COVID-19 pandemic. Resolution of the Expert Council of the Russian Society for the Prevention of Noncommunicable Diseases O. M. Drapkina, S. N. Avdeev, A. V. Gorelov, V. P. Chulanov, L. I. Alekseeva, A. B. Danilov, et al. (+2)
42 [GO] 2022―Feb―28 Effusive pericarditis in the pathogenesis of cardiac arrhythmias in COVID-19: a case series Z. N. Sukmarova, M. A. Saidova, Yu. V. Ovchinnicov
43 [GO] 2022―Feb―28 Additional evidence against widespread use of inpatient antiplatelet therapy in coronavirus infection: data from a randomized controlled trial I. S. Yavelov
44 [GO] 2022―Jan―12 The possibilities of using antiplatelet agents during and after COVID-19 disease. Results of the Expert Council meeting Article Editorial
45 [GO] 2022―Jan―12 Dynamics of age characteristics and prevalence of concomitant cardiovascular and non-sardiovascular diseases in patients hospitalized with COVID-19 during epidemic wave: data from TARGET-VIP registry M. M. Lukyanov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, et al. (+13)
46 [GO] 2022―Jan―12 The outpatient medical care in patients with chronic diseases under dispensary supervision in the conditions of the COVID-19 pandemic. Temporary guidelines. Version 2 O. M. Drapkina, L. Y. Drozdova, S. N. Avdeev, S. A. Boytsov, E. S. Ivanova, А. D. Kaprin, et al. (+8)
47 [GO] 2021―Nov―28 Association of COVID-19 lockdown measures with changes in physical activity of the adult population of Russia D. K. Mukaneeva, A. V. Kontsevaya, A. A. Antsiferova, I. N. Khalfiev, A. A. Seledtsov, E. A. Stolyarova, et al. (+4)
48 [GO] 2021―Nov―28 Clinical and anamnestic characteristics of patients with non-ST elevation myocardial infarction after COVID-19 M. G. Chashchin, A. Yu. Gorshkov, O. M. Drapkina, I. V. Kositsyna, A. V. Golubev, N. I. Chaus, S. N. Perekhodov
49 [GO] 2021―Okt―16 Hydrogen inhalation in rehabilitation program of the medical staff recovered from COVID-19 L. V. Shogenova, Thi Tuet Truong, N. O. Kryukova, K. A. Yusupkhodzhaeva, D. D. Pozdnyakova, T. G. Kim, et al. (+11)
50 [GO] 2021―Okt―16 Single-center register of myocardial revascularization in patients with coronary artery disease and acute coronary syndrome in the context of COVID-19 pandemic O. V. Kamenskaya, A. S. Klinkova, I. Yu. Loginova, V. N. Lomivorotov, A. M. Chernyavskiy, V. V. Lomivorotov
51 [GO] 2021―Sep―12 COVID-19 as a cause of chronic pulmonary hypertension: pathophysiological rationale and potential of instrumental investigations E. Kobelev, T. A. Bergen, A. R. Tarkova, O. Ya. Vasiltseva, O. V. Kamenskaya, V. Yu. Usov, A. M. Chernyavsky
52 [GO] 2021―Sep―12 Acute coronary syndrome in COVID-19 patients M. G. Chashchin, A. Yu. Gorshkov, O. M. Drapkina
53 [GO] 2021―Jul―18 Thrombectomy vs conservative therapy in patients with COVID-19 A. N. Kazantsev
54 [GO] 2021―Jul―18 COVID-19 and cardiovascular comorbidity: novel approaches to reduce mortality S. S. Bunova, P. I. Okhotnikova, Yu. P. Skirdenko, N. A. Nikolaev, O. A. Osipova, N. I. Zhernakova
55 [GO] 2021―Jul―18 Algorithms for adult outpatient care of coronavirus disease 2019 (COVID-19) and its Assumption M. A. Livzan, O. M. Drapkina, N. A. Nikolaev, Y. P. Skirdenko, R. N. Shepel, I. A. Viktorova, et al. (+15)
56 [GO] 2021―Jul―18 Acute lower limb ischemia in the context of the COVID-19 pandemic I. A. Vinokurov
57 [GO] 2021―Jul―18 Surgical thrombectomy versus conservative treatment in cases of acute limb ischemia with COVID-19 pneumonia A. M. Fahad, H. A. Alkhalidi, Y. Q. M. Altimimi
58 [GO] 2021―Jul―18 Mehman Mamedov: case management during and after coronavirus pandemic Article Editorial
59 [GO] 2021―Mai―15 COVID-19 from the interdisciplinary standpoint. Round table M. N. Mamedov, Yu. V. Rodionova, I. S. Yavelov, M. I. Smirnova, E. N. Dudinskaya, V. I. Potievskaya
60 [GO] 2021―Mai―15 Proteolytic enzyme and adiponectin receptors as potential targets for COVID-19 therapy K. A. Rubina, N. R. Sabitova, A. Yu. Efimenko, N. I. Kalinina, J. A. Akopyan, E. V. Semina
61 [GO] 2021―Feb―20 Clinical and laboratory characteristics of patients with COVID-19 and concomitant type 2 diabetes T. Yu. Demidova, K. G. Lobanova, S. N. Perekhodov, M. B. Antsiferov, O. Sh. Oynotkinova
62 [GO] 2020―Dez―31 COVID-19 biobank: features of the cytokine profile N. N. Sushentseva, O. S. Popov, S. V. Apalko, A. Yu. Anisenkova, S. V. Azarenko, K. V. Smantserev, et al. (+8)
63 [GO] 2020―Dez―31 Prospective in-hospital registry of patients with suspected or documented COVID-19 infection and community-acquired pneumonia (TARGET-VIP): characteristics of patients and assessment of in-hospital outcomes O. M. Drapkina, O. E. Karpov, M. M. Lukyanov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, et al. (+13)
64 [GO] 2020―Dez―31 Work within the COVID-19 pandemic - the experience of the biobank of the National Medical Research Center of Oncology I. V. Samokhina, A. B. Sagakyants
65 [GO] 2020―Jul―03 Debatable points of using angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in patients with COVID-19 O. M. Drapkina, L. E. Vasilyeva
66 [GO] 2020―Jul―03 COVID-19 and nutrition: new emphases, old priorities (review of guidelines) N. S. Karamnova, O. M. Drapkina
67 [GO] 2020―Jul―03 Health promotion and prevention of chronic non-communicable diseases in the context of the COVID-19 pandemic. Consensus of experts of the National society of evidence-based pharmacotherapy and the Russian society of the prevention of non-communicable diseases O. M. Drapkina, M. G. Gambaryan, B. E. Gorny, N. S. Karamnova, A. V. Kontsevaya, N. K. Novikova, et al. (+3)
68 [GO] 2020―Jul―03 Tobacco smoking and COVID-19: an old enemy in a new guise. Review of current publications M. G. Gambaryan, O. M. Drapkina
69 [GO] 2020―Jul―03 COVID-19: urgent questions for estimating morbidity, prevalence, case fatality rate and mortality rate O. M. Drapkina, I. V. Samorodskaya, M. G. Sivtseva, E. P. Kakorina, N. I. Briko, S. N. Cherkasov, et al. (+2)
70 [GO] 2020―Jul―03 Novel coronavirus infection SARS-CoV-2 in elderly and senile patients: prevention, diagnosis and treatment. Expert Position Paper of the Russian Association of Gerontology and Geriatrics O. N. Tkacheva, Yu. V. Kotovskaya, L. A. Aleksanyan, A. S. Milto, A. V. Naumov, I. D. Strazhesko, et al. (+15)
71 [GO] 2020―Jun―25 Management of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020 V. B. Grinevich, I. V. Gubonina, V. L. Doshchitsin, Yu. V. Kotovskaya, Yu. A. Kravchuk, V. I. Ped, et al. (+6)
72 [GO] 2020―Mai―11 Self-monitoring and treatment of chronic non-communicable diseases in the context of the COVID-19 pandemic. Consensus of experts of the National society of evidence-based pharmacotherapy and the Russian society of the prevention of non-communicable diseases S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina, S. N. Tolpygina, L. P. Ivanova, N. A. Dmitrieva, et al. (+2)
73 [GO] 2020―Mai―11 COVID-19: hemostatic parameters and specifics of antithrombotic treatment I. S. Yavelov, O. M. Drapkina
 [1] 

73 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec